Ebola vaccine, which is said to be 100% effective for Ebola hemorrhagic fever, will be put into practical use within 2 years

ByNIAID

From the end of 2013 it has been raging for more than two years, and it was decided to inform the world of the name "Ebola fever heat". Ebola virus, which is said to be one of the most dangerous viruses found by human beings, is a dangerous virus with some types of viruses that have a mortality rate of 50 to 80% if infected, but this vaccine will be put to practical use by the end of 2017 It is revealed that it is promising.

Merck to Submit Ebola Vaccine for Approval by End of 2017 - Bloomberg Business
http://www.bloomberg.com/news/articles/2016-01-20/merck-to-submit-ebola-vaccine-for-approval-by-end-of-2017


January 14, 2016,World Health Organization(WHO) was prevalent in Liberia in West AfricaDeclare the end of Ebola hemorrhagic feverDid.West African Ebola hemorrhagic fever outbreak in 2014In December 2013 about two years, the death toll of 11,315 people, mainly in the three West African countries. Although the end was declared, the World Health Organization (WHO) announced that "International public health emergenciesPHEIC) "Has not been released," it is possible to recurrence "that it is a policy to continue to monitor. In addition, deaths due to Ebola hemorrhagic fever have been confirmed in the Republic of Sierra Leone just one day after the end of the WHO declaration, and it can be said that there is still a situation that is unpredictable.

By# ISurvived Ebola

A research result on Ebola vaccine "100% effective" for such Ebola virus is a medical information magazine in the UK in July 2015The LancetsoReleaseIt was done. This Ebola vaccine was developed by the global pharmaceutical company headquartered in New Jersey, USAMerck & Co."The effect was demonstrated for more than 4000 subjects who were in contact with patients with Ebola outpatient fever in Guinea.

Such an organization that Merck & Co. is actively providing funds for the development of the most Ebola vaccine in the world now "GAVI Alliance"We aimed for practical application by the end of 2017 that we have signed a contract to develop Ebola vaccineBloomberg BusinessIt reports.

ByNIAID

The GAVI Alliance is a comprehensive framework for governments, companies, UN agencies, and evenBill & Melinda Gates FoundationAs a cost to develop Ebola vaccines from charity organizations such as Merck & Co., Inc. has collected a total of 5 million dollars (about 580 million yen), and it seems that Merck & Co. will tackle the development of vaccines using this fund. Merck & Co. announced that it will prepare 300,000 Ebola vaccines for clinical trials and emergency situations by May 2016 and at the same time feel the Ebola vaccine emergency use against WHO I also reveal that I submitted my application form. The contract between Merck & Co. and GAVI Alliance is held in Davos, SwitzerlandWorld Economic ForumIt is said that it was revealed within the annual general meeting of.

Dr. Seth Berkeley, CEO of the GAVI Alliance, said at the announcement of the contract, "We must show that we are better prepared for the spread of infectious diseases by learning from the devastating crisis of Ebola hemorrhagic fever" I am talking.